Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer
Clinical trial NCT04214262 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04214262
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-13
- Primary completion
- 2024-08-24
- Enrollment
- 415
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.